Edition:
United States

Thermo Fisher Scientific Inc (TMO)

TMO on New York Consolidated

172.57USD
18 Aug 2017
Change (% chg)

$-0.32 (-0.19%)
Prev Close
$172.89
Open
$172.56
Day's High
$174.36
Day's Low
$172.15
Volume
1,182,702
Avg. Vol
1,447,929
52-wk High
$182.87
52-wk Low
$139.07

Select another date:

Mon, Aug 14 2017

BRIEF-Appaloosa LP cuts share stake in GM, ups in Thermo Fisher

* Appaloosa LP says cuts share stake in General Motors to 1.9 million shares from 5.2 million shares - SEC filing‍​

BRIEF-Thermo Fisher Scientific prices an offering of $1.5 bln aggregate principal amount

* Priced an offering of $1.5 billion aggregate principal amount

BRIEF-Thermo Fisher Scientific files preliminary prospectus supplement related to a potential two-part notes offering

* Files preliminary prospectus supplement related to a potential two-part notes offering Source text: (http://bit.ly/2fuz7Wc) Further company coverage:

BRIEF-Thermo Fisher prices offering of common stock at $171 per share

* Priced its underwritten public offering of 8,771,930 shares of common stock at a price of $171.00 per share Source text for Eikon: Further company coverage:

BRIEF-Thermo Fisher extends cash tender offer for all outstanding shares of Patheon

* Thermo Fisher extends cash tender offer for all outstanding shares of Patheon to coordinate offer timing with two remaining regulatory approvals

BRIEF-Thermo Fisher Scientific announces $1.5 billion offering of common stock

* Thermo Fisher Scientific - intends to use all of net proceeds of offering to fund a portion of consideration payable for its acquisition of Patheon N.V. Source text for Eikon: Further company coverage:

BRIEF-FDA issues emergency use authorization for Thermo Fisher Scientific's Zika virus assay

* FDA issues emergency use authorization for Thermo Fisher Scientific's zika virus assay

BRIEF-Thermo Fisher Scientific Inc announced successful CE-IVD registration of its QuantStudio 5 Dx real-time PCR system for sale in European countries

* Thermo Fisher Scientific Inc - announced successful CE-IVD registration of its QuantStudio 5 Dx Real-Time PCR system for sale in European countries

BRIEF-Thermo Fisher Scientific Q2 adjusted earnings of $2.30 per share

* Q2 revenue grew 10 percent to $4.99 billion, versus $4.54 billion in Q2 2016

Thermo Fisher quarterly results edge past estimates, ups forecast

Thermo Fisher Scientific Inc on Wednesday reported quarterly profit and revenue slightly ahead of analysts' estimates, helped by increased sales across its businesses, and raised its full-year earnings and revenue forecasts.

Select another date: